Arvinas is a clinical-stage biotechnology company focused on developing therapies to degrade disease-causing proteins using its PROTAC Discovery Engine. The company progresses investigational drugs like vepdegestrant for breast cancer, ARV-393 for lymphoma, and ARV-102 for neurodegenerative disorders. Based in New Haven, CT, Arvinas is committed to improving patient lives with a dedicated team.
Arvinas is a clinical-stage biotechnology company focused on developing therapies to treat debilitating diseases. They are currently expanding into the treatment of neurodegenerative disorders, with plans for FDA approval of their vepdegestrant for estrogen receptor-positive breast cancer, and clinical trials for ARV-766 and ARV-393. This role is for a Senior Director of Clinical Scientist focused on providing scientific support and contributing to clinical development activities, with a focus on data analysis, manuscript preparation, and communication.
Arvinas is a clinical-stage biotechnology company focused on developing therapies to degrade disease-causing proteins using its PROTAC Discovery Engine. The company progresses investigational drugs like vepdegestrant for breast cancer, ARV-393 for lymphoma, and ARV-102 for neurodegenerative disorders. Based in New Haven, CT, Arvinas is committed to improving patient lives with a dedicated team.
BioNTech SE